Thomas Kassberg

Tom Kassberg currently serves as the Chief Business Officer at Ultragenyx Pharmaceutical Inc., a position held since November 2011. Prior experience includes roles as VP of Business Development at Corium International and Consultant in Business Development - Biotech. Kassberg has also held the Chief Business Officer role at Rib-X Pharmaceuticals and served as Executive VP of Corporate Development at Proteolix. Additional positions include Sr. VP Corporate Development and Commercial Ops at InterMune, VP Corporate Development at Plexxikon Inc., Sr. Director of Business Development at Pharmacia, and Senior Director of Business Development at SUGEN, Inc. Educational credentials include an MBA in Management from Northwestern University - Kellogg School of Management and a degree from Gustavus Adolphus College.